Funding for research on managing health conditions in low-income countries and US tribal populations through implementation strategies.
National Institutes of Health has archived this opportunity.
Funder: National Institutes of Health
Due Dates: February 7, 2025 (New/Renewal/Resubmission/Revision) | May 7, 2025 (AIDS) | November 5, 2025 (New) | January 7, 2026 (AIDS) | November 5, 2026 (Renewal/Resubmission/Revision)
Funding Amounts: No set budget limit; typical direct costs up to $500,000/year; project period up to 5 years (1-year R61, up to 4-year R33 phase).
Summary: Supports implementation research to improve integrated, patient-centered care for non-communicable disease multimorbidity in low- and middle-income countries and US Tribal populations.
Key Information: Clinical trial required; both R61 (planning) and R33 (implementation) phases must be addressed; US applicants must include LMIC partners as key personnel.
This NIH opportunity, in partnership with the Global Alliance for Chronic Diseases (GACD), funds implementation research to improve the availability, integration, and effectiveness of patient-centered care for people living with multiple long-term non-communicable diseases (NCDs) in World Bank-defined low- and middle-income countries (LMICs) and/or American Indian/Alaska Native (AI/AN) Tribal Nation populations in the US. The program aims to support innovative strategies to overcome barriers to the adoption, adaptation, scale-up, and sustainability of evidence-based interventions for NCD multimorbidity, with a strong emphasis on health equity, local context, and capacity building.
Projects must use a bi-phasic, milestone-driven R61/R33 mechanism: an initial 1-year R61 planning phase, with possible transition to a 4-year R33 implementation phase, contingent on meeting predefined milestones.